dbRUSP: An Interactive Database to Investigate Inborn Metabolic Differences for Improved Genetic Disease Screening

dbRUSP: An Interactive Database to Investigate Inborn Metabolic Differences for Improved Genetic Disease Screening

The Recommended Uniform Screening Panel (RUSP) contains more than forty metabolic disorders recommended for inclusion in universal newborn screening (NBS). Tandem-mass-spectrometry-based screening of metabolic analytes in dried blood spot samples identifies most affected newborns, along with a numbe...

Full description

Bibliographic Details
Main Authors:	Gang Peng, Yunxuan Zhang, Hongyu Zhao, Curt Scharfe
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	International Journal of Neonatal Screening
Subjects:	newborn screening inborn metabolic disorders tandem mass spectrometry false positive screen second-tier testing
Online Access:	https://www.mdpi.com/2409-515X/8/3/48

Similar Items

Reducing False-Positive Results in Newborn Screening Using Machine Learning
by: Gang Peng, et al.
Published: (2020-03-01)

Development of Strategies to Decrease False Positive Results in Newborn Screening
by: Sabrina Malvagia, et al.
Published: (2020-11-01)

Application of the Artificial Intelligence Algorithm Model for Screening of Inborn Errors of Metabolism
by: Muping Zhou, et al.
Published: (2022-05-01)

Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region
by: Álvaro Martín‐Rivada, et al.
Published: (2022-03-01)

Selective screening in neonates suspected to have inborn errors of metabolism
by: Rabah M. Shawky, et al.
Published: (2015-04-01)

Use of Molecular Genetic Analyses in Danish Routine Newborn Screening
by: Allan Meldgaard Lund, et al.
Published: (2021-07-01)

Evaluation of diagnostic accuracy of biomarkers of inborn errors of metabolism in sick neonates: A prospective observational study
by: N.B. Mathur, et al.
Published: (2021-04-01)

Newborn screening of inherited metabolic disorders by tandem mass spectrometry: past, present and future
by: G. Scaturro, et al.
Published: (2013-04-01)

Newborn Screening: Current Status in Alberta, Canada
by: Andy De Souza, et al.
Published: (2019-10-01)

Application of Next-Generation Sequencing Following Tandem Mass Spectrometry to Expand Newborn Screening for Inborn Errors of Metabolism: A Multicenter Study
by: Yuqi Yang, et al.
Published: (2019-02-01)

Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
by: Eric R. Bialk, et al.
Published: (2019-09-01)

Cost-effectiveness analysis of newborn screening by tandem mass spectrometry in Shenzhen, China: value and affordability of new screening technology
by: Mingren Yu, et al.
Published: (2022-08-01)

A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns
by: Takanori Onuki, et al.
Published: (2023-08-01)

Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population
by: Ting Wang, et al.
Published: (2019-10-01)

Validation of amplicon-based next generation sequencing panel for second-tier test in newborn screening for inborn errors of metabolism
by: Tsang Kwok Yeung, et al.
Published: (2021-12-01)

Expanded Newborn Screening for Inborn Errors of Metabolism in Hong Kong: Results and Outcome of a 7 Year Journey
by: Kiran Moti Belaramani, et al.
Published: (2024-03-01)

A retrospective analysis of MS/MS screening for IEM in high-risk areas
by: Xiao He, et al.
Published: (2023-03-01)

Newborn Screening for Fabry Disease: Current Status of Knowledge
by: Vincenza Gragnaniello, et al.
Published: (2023-06-01)

Selective screening for inborn errors of metabolism using tandem mass spectrometry in West Kazakhstan children: study protocol
by: Gulmira Zharmakhanova, et al.
Published: (2024-01-01)

Metabolomic Studies in Inborn Errors of Metabolism: Last Years and Future Perspectives
by: Marcello Cossu, et al.
Published: (2023-03-01)

Association of Maternal Age and Blood Markers for Metabolic Disease in Newborns
by: Yuhan Xie, et al.
Published: (2023-12-01)

Inborn errors of amino acid metabolism – from underlying pathophysiology to therapeutic advances
by: Shira G. Ziegler, et al.
Published: (2023-11-01)

Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany *
by: Mengel Eugen, et al.
Published: (2011-06-01)

Harnessing Next-Generation Sequencing as a Timely and Accurate Second-Tier Screening Test for Newborn Screening of Inborn Errors of Metabolism
by: Toby Chun Hei Chan, et al.
Published: (2024-03-01)

Editorial: Newborn Screening for Inborn Errors of Metabolism: Is It Time for a Globalized Perspective Based on Genetic Screening?
by: Mohamed A. Elmonem, et al.
Published: (2021-09-01)

Inborn Errors of Metabolism
by: Erich Maul
Published: (2009-05-01)

Increased detection of primary carnitine deficiency through second-tier newborn genetic screening
by: Yiming Lin, et al.
Published: (2021-03-01)

The Combined Impact of CLIR Post-Analytical Tools and Second Tier Testing on the Performance of Newborn Screening for Disorders of Propionate, Methionine, and Cobalamin Metabolism
by: Dimitar K. Gavrilov, et al.
Published: (2020-04-01)

The modern face of newborn screening
by: Yin-Hsiu Chien, et al.
Published: (2023-02-01)

Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience
by: Vincenza Gragnaniello, et al.
Published: (2021-06-01)

Expanded newborn screening for inherited metabolic disorders by tandem mass spectrometry in a northern Chinese population
by: Hong Zhang, et al.
Published: (2022-09-01)

Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature
by: Vincenza Gragnaniello, et al.
Published: (2020-11-01)

Performance of the Four-Plex Tandem Mass Spectrometry Lysosomal Storage Disease Newborn Screening Test: The Necessity of Adding a 2nd Tier Test for Pompe Disease
by: Shu-Chuan Chiang, et al.
Published: (2018-12-01)

Timing of Newborn Blood Collection Alters Metabolic Disease Screening Performance
by: Gang Peng, et al.
Published: (2021-01-01)

Analysis of 2-methylcitric acid, methylmalonic acid, and total homocysteine in dried blood spots by LC-MS/MS for application in the newborn screening laboratory: A dual derivatization approach
by: Joshua A. Dubland, et al.
Published: (2021-04-01)

Perception towards newborn screening
by: Sridhar Amalakanti, et al.
Published: (2023-01-01)

Successful Implementation of Expanded Newborn Screening in the Philippines Using Tandem Mass Spectrometry
by: Carmencita D. Padilla, et al.
Published: (2022-01-01)

First-tier next-generation sequencing for newborn screening: An important role for biochemical second-tier testing
by: Sarah L. Stenton, et al.
Published: (2023-01-01)

Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants
by: Tülay Güran, et al.
Published: (2019-03-01)

Portuguese Neonatal Screening Program: A Cohort Study of 18 Years Using MS/MS
by: Maria Miguel Gonçalves, et al.
Published: (2024-03-01)